1-4 of 4
lmb-2 immunotoxin
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Regression of Adult T-Cell Leukemia with Anti-CD25 Recombinant Immunotoxin LMB-2 Preceded by Chemotherapy

Robert J. Kreitman, MD, Rajat Singh, Maryalice Stetler-Stevenson, MD, PhD, Thomas A. Waldmann, MD, Ira Pastan, MD
Journal: Blood
Blood (2011) 118 (21): 2575.
https://doi.org/10.1182/blood.V118.21.2575.2575
Published: 2011
Journal Articles

Improvement of Selective Depletion of Alloreactive T Cells.

Erkut Bahceci, Marina Komarovskaya, Robert Kreitman, Dennis Cooper, Ira Pastan
Journal: Blood
Blood (2005) 106 (11): 1067.
https://doi.org/10.1182/blood.V106.11.1067.1067
Published: 2005
Journal Articles

Sensitization of B-cell chronic lymphocytic leukemia cells to recombinant immunotoxin by immunostimulatory phosphorothioate oligodeoxynucleotides

Thomas Decker, Susanne Hipp, Robert J. Kreitman, Ira Pastan, Christian Peschel, Thomas Licht
Journal: Blood
Blood (2002) 99 (4): 1320–1326.
https://doi.org/10.1182/blood.V99.4.1320.h8001320_1320_1326
Published: 2002
Journal Articles

Responses in Refractory Hairy Cell Leukemia to a Recombinant Immunotoxin

Robert J. Kreitman, Wyndham H. Wilson, David Robbins, Inger Margulies, Maryalice Stetler-Stevenson, Thomas A. Waldmann, Ira Pastan
Journal: Blood
Blood (1999) 94 (10): 3340–3348.
https://doi.org/10.1182/blood.V94.10.3340.422k19_3340_3348
Published: 1999